TR200102604T2 - A method for increasing the stability of photosensitive therapeutic systems and their components during administration and / or storage. - Google Patents

A method for increasing the stability of photosensitive therapeutic systems and their components during administration and / or storage.

Info

Publication number
TR200102604T2
TR200102604T2 TR2001/02604T TR200102604T TR200102604T2 TR 200102604 T2 TR200102604 T2 TR 200102604T2 TR 2001/02604 T TR2001/02604 T TR 2001/02604T TR 200102604 T TR200102604 T TR 200102604T TR 200102604 T2 TR200102604 T2 TR 200102604T2
Authority
TR
Turkey
Prior art keywords
storage
stability
therapeutic systems
increasing
components during
Prior art date
Application number
TR2001/02604T
Other languages
Turkish (tr)
Inventor
Berthold Achim
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200102604T2 publication Critical patent/TR200102604T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Elektromanyetik dalgalari soguran ya da yansitan isik stabilite ajanlarini kullanmak suretiyle isiga duyarli törapötik sistemler ile erken ve yardimci maddeler gibi bunlara ait bilesenlerin tatbiki ve/veya saklanmasi sirasinda stabilitelerinin artirilmasina iliskin yöntem, ki bu süreç absorbsiyon veya yansima spektrumu, dalgaboyunun isiga duyarli materyalin ya da buna ait bilesenin kararsizligindan sorumlu olan araligini içine alan absorbsiyon ve refleksiyon ajanlarinin kullanilmasi ile karakterizedir.The method for enhancing their stability during the application and / or storage of light-sensitive therapeutic systems and their components, such as by absorbing or reflecting electromagnetic waves, and early and auxiliary substances, which process absorption or reflection spectrum, wavelength of light-sensitive material It is characterized by the use of absorption and reflection agents, which includes the range of the component responsible for the instability of the component.

TR2001/02604T 1999-03-20 2000-03-08 A method for increasing the stability of photosensitive therapeutic systems and their components during administration and / or storage. TR200102604T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19912623A DE19912623A1 (en) 1999-03-20 1999-03-20 Process for increasing the stability when storing and / or using light-sensitive therapeutic systems or their components

Publications (1)

Publication Number Publication Date
TR200102604T2 true TR200102604T2 (en) 2002-01-21

Family

ID=7901787

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02604T TR200102604T2 (en) 1999-03-20 2000-03-08 A method for increasing the stability of photosensitive therapeutic systems and their components during administration and / or storage.

Country Status (13)

Country Link
EP (1) EP1162957A1 (en)
JP (1) JP2002539238A (en)
KR (1) KR20010114231A (en)
CN (1) CN1343117A (en)
AR (1) AR023100A1 (en)
AU (1) AU771819B2 (en)
BR (1) BR0010516A (en)
CA (1) CA2366859A1 (en)
DE (1) DE19912623A1 (en)
HK (1) HK1039277A1 (en)
TR (1) TR200102604T2 (en)
WO (1) WO2000056289A1 (en)
ZA (1) ZA200107523B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053375C1 (en) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermal therapeutic system with light-sensitive agent in polymer matrix and backing, useful for therapy with e.g. nicotine, nifedipine, lacidipine, gestagen, vitamin B 12 or antibiotic, contains colorless ultraviolet absorber
BRPI0407615B8 (en) 2003-02-21 2021-05-25 Bayer Ip Gmbh UV stable transdermal therapeutic system
DE10317692A1 (en) 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medical active substance patches with reduced optical conspicuity on the skin
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
CN101068546A (en) * 2004-10-06 2007-11-07 卫材R&D管理有限公司 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102010050242A1 (en) 2010-10-30 2012-05-03 Schott Ag Drug package for delivery of drugs, and for encapsulation and storage of fragrances and chemical indicators, comprises impermeable surface shaped cavity made of thin glass, where cavity is provided for containing active ingredient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5832821A (en) * 1981-08-20 1983-02-25 Sumitomo Bakelite Co Ltd Light screening packaged material containing photodegradable medicine
EP0143857B1 (en) * 1983-11-30 1988-04-06 Siegfried Aktiengesellschaft Therapeutic coronary composition in the form of soft gelatine capsules
JPS61293911A (en) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk Sustained release preparation
JPH03145421A (en) * 1989-10-31 1991-06-20 Zeria Pharmaceut Co Ltd Stable eye drop
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
US5268179A (en) * 1992-02-14 1993-12-07 Ciba-Geigy Corporation Ultrasonically sealed transdermal drug delivery systems
JPH07204251A (en) * 1993-10-15 1995-08-08 Dai Ichi Seiyaku Co Ltd Quinolon antibacterial preparations

Also Published As

Publication number Publication date
AU771819B2 (en) 2004-04-01
WO2000056289A1 (en) 2000-09-28
ZA200107523B (en) 2002-11-27
KR20010114231A (en) 2001-12-31
EP1162957A1 (en) 2001-12-19
CN1343117A (en) 2002-04-03
BR0010516A (en) 2003-07-22
AR023100A1 (en) 2002-09-04
DE19912623A1 (en) 2000-09-28
CA2366859A1 (en) 2000-09-28
JP2002539238A (en) 2002-11-19
HK1039277A1 (en) 2002-04-19
AU3809100A (en) 2000-10-09

Similar Documents

Publication Publication Date Title
FI972917A (en) Foams made from high internal phase emulsions useful as absorbent components for menstrual pads
BR0305316A (en) Hinge
DE69130709T2 (en) TARGETED IMMUNOSTIMULATION WITH SPECIFIC SUBSTANCES
DK0934937T3 (en) Azole derivatives as superoxide radical inhibitor
SE9301539L (en) Non-Migrating 1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidine-1,3,5-triazine derivative as polymer stabilizer
TR200102604T2 (en) A method for increasing the stability of photosensitive therapeutic systems and their components during administration and / or storage.
FI925615A (en) Stabilized pharmaceutical compositions comprising an HMG-CoA reductant inhibitor compound
DE69721153D1 (en) Packaging of an optoelectronic component
DK0639186T3 (en) Taxol derivatives
TW360700B (en) Antireflective coating compositions
ATE233539T1 (en) FOAM LIGHT PREPARATIONS CONTAINING WATER-SOLUBLE LIGHT PROTECTION SUBSTANCES AND SURFACE-ACTIVE SUBSTANCES
EP0834770A3 (en) Dyed photoresists and methods and articles of manufacture comprising same
DE602004013562D1 (en) IMPROVEMENTS OF OPTICAL SEMICONDUCTOR DEVICES WITH VERTICAL RESONATOR
AR012673A1 (en) MONOHIDROBENZOPORPHYRINE ETHYLENE GLYCOL ESTER COMPOUND USEFUL FOR PHOTODYNAMIC THERAPY, PHARMACEUTICAL COMPOSITIONS AND USE THEREFOR.
DE69428080T2 (en) Optically active 2-imidazoline-5-one derivatives as fungicides
DE69908311T2 (en) MULTIPLE CORNER KIRKPATRICK-BAEZ OPTICAL BEAM TREATMENT ARRANGEMENT
ATE489565T1 (en) TRAILER MOUNTED BURSTING ENERGY ABSORPTION SYSTEM
ATE248752T1 (en) FOLDABLE PROTECTIVE PACKAGING
FI955643A0 (en) N-alkylthiopolyamine derivatives as radiation protection agents
TR199900195T2 (en) Composition of the vaccine against malaria.
DE69220664D1 (en) CATIONIC POLYSACCHARID
YU47240B (en) Dual-axis optical inertia system that uses a gyroscope rotor as a stable reference
EP1180717A3 (en) Optical harmonic generator
EA200000092A1 (en) ANTIALLERGICAL MEANS
FI961339A0 (en) Triarylethylene derivatives for use in therapy